RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 164 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,049 | +126.6% | 971,441 | +170.9% | 0.09% | +95.7% |
| Q2 2023 | $463 | +8.2% | 358,626 | +10.6% | 0.05% | +9.5% |
| Q1 2023 | $428 | +199.3% | 324,398 | +240.5% | 0.04% | +133.3% |
| Q4 2022 | $143 | -100.0% | 95,269 | -17.2% | 0.02% | -58.1% |
| Q3 2021 | $418,000 | +660.0% | 115,036 | +617.0% | 0.04% | +377.8% |
| Q1 2021 | $55,000 | -64.5% | 16,043 | -81.0% | 0.01% | -89.5% |
| Q2 2020 | $155,000 | -56.0% | 84,429 | -62.6% | 0.09% | -2.3% |
| Q1 2020 | $352,000 | -33.0% | 225,547 | -8.1% | 0.09% | +44.3% |
| Q4 2019 | $525,000 | +39.6% | 245,487 | +22.1% | 0.06% | +19.6% |
| Q3 2019 | $376,000 | +317.8% | 201,128 | +620.9% | 0.05% | +920.0% |
| Q3 2018 | $90,000 | +73.1% | 27,900 | +110.1% | 0.01% | +25.0% |
| Q1 2014 | $52,000 | – | 13,281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |